120 likes | 196 Views
Global Cancer gene therapy Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023
E N D
Global Cancer Gene Therapy Market Research and Forecast 2018-2023 Biotechnology Healthcare
DEFINITION Gene therapy is a process to treat or prevent disease replacing the mutated genes with healthy genes. This replacement allows the cells for the production of useful proteins. It can also change the way genes are generated. This enables under- or overactive genes to operate properly. Gene therapy can be used for expressing entirely foreign genes in cells that alter their function or survival. During cancer treatment, the genes are replaced for fighting against carcinogenic tumor cells. Cancer gene therapy market inserts therapeutic DNA into the patient for the treatment of cancer. It is considered to be an effective treatment for cancer as it causes minimum side effects with maximum efficacy.
MARKET MOTIVATORS • Rising pool of population with cancer patients • Increasing funding in r&d of cancer gene therapy • Rising geriatric population base • Technological advancement such as car t-cell therapy
MARKET RESTRAINTS • High cost of treatment
MARKET OPPORTUNITIES • Untapped market in emerging economies • Partnership & collaborations among the players to develop and launch gene therapy products
MARKET SEGMENTATION By therapy • Gene transfer immunotherapy • Oncolyticvirotherapy • Gene induced immunotherpay
MARKET SEGMENTATION By end users • Hospitals • Research institutes • Biotech companies
COMPANY PROFILES • Achilles therapeutics ltd. • Adaptimmune therapeutics plc • American gene technologies international inc. • Ani pharmaceuticals, inc. • Autolus therapeutics plc To be continued….
FOR MORE DETAILS PLEASE VISIT OUR WEBSITE CONTACT US Orion Market Research Pvt. Ltd. (OMR Global)116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya PradeshIndia- 452010 Global +1 646-755-7667 Asia +91 917-982-8694 info@omrglobal.com https://www.omrglobal.com 10